Proper urinary elimination is a key indicator of your overall health, especially as you get older. If your ability to urinate is impaired, it can cause a wide variety of other conditions. Impaired ...
Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ...
Myrbetriq (mirabegron) is a brand-name drug that’s prescribed for overactive bladder in adults and certain children. It’s an extended-release medication. As with other drugs, Myrbetriq can cause side ...
The approval was based on data from the pivotal phase 3 EMPOWUR study. The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron; Urovant Sciences) for the treatment of overactive ...
University of Colorado Boulder researchers have developed a new, gecko-inspired drug-delivery technology that has the potential to improve treatments for bladder cancer. Geckos have properties in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback